# ENSO 16 - Study in Healthy Subjects

> **NCT05457400** · PHASE1 · COMPLETED · sponsor: **Alpha Republic GmbH** · enrollment: 15 (actual)

## Conditions studied

- Sugar; Blood, Low

## Interventions

- **DRUG:** ENSO 16
- **DRUG:** Glucose Powder

## Key facts

- **NCT ID:** NCT05457400
- **Lead sponsor:** Alpha Republic GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-28
- **Primary completion:** 2022-06-14
- **Final completion:** 2022-07-29
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05457400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05457400, "ENSO 16 - Study in Healthy Subjects". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05457400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*